---
aliases: [TEM]
---
#actor #healthcare #ai #usa #public

**Tempus** — AI-native healthcare company. Precision medicine, genomic testing, clinical data platform.

---

## Why Tempus matters

| Metric | Value |
|--------|-------|
| Market cap | ~$10B |
| Ticker | TEM (NASDAQ) |
| Data library | 200M+ clinical records |
| Focus | Oncology, cardiology, neuropsych |

---

## AI-first healthcare

| Capability | Description |
|------------|-------------|
| Genomic sequencing | Tumor profiling |
| Clinical data | Largest real-world oncology dataset |
| AI models | Treatment recommendations |
| Drug discovery | Pharma partnerships |

**Moat:** Data flywheel — more tests → more data → better AI → more adoption.

---

## Business segments

| Segment | Description |
|---------|-------------|
| Genomics | Testing services (Tempus xT, xF, xG) |
| Data/Services | Pharma partnerships, analytics |
| Insights | AI-powered clinical decision support |

---

## Investment case

**Bull:**
- AI-native from founding
- Data moat (200M+ records)
- Precision medicine secular trend
- Pharma partnership revenue
- Eric Lefkofsky founder (Groupon exit)

**Bear:**
- Path to profitability unclear
- Competition (Foundation Medicine/Roche)
- Healthcare AI adoption slow
- Reimbursement challenges

---

## Related

- [[Agentic AI]] — clinical decision support
- [[Eli Lilly]], [[Pfizer]] — pharma partners
